<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8" /><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1044.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","queueTime":0,"licenseKey":"cd1101aa94","agent":"","transactionName":"bgcDMkBZW0NZBkdcWVdNJxNcW0FZVwscV1dKB08QW11CQxYTWlBBZgEOC19dW0QCEVtHU1gG","applicationID":"6369297","errorBeacon":"bam.nr-data.net","applicationTime":271}</script>
    <title>Protein (target, carrier, transporter, and enzyme) interactions in DrugBank | Thinklab</title>
	  <link rel="shortcut icon" href="https://think-lab.s3.amazonaws.com/s/img/favicon.ico" type="image/x-icon" />
    <meta property="og:image" content="https://think-lab.s3.amazonaws.com/s/img" />
    
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/css/bootstrap.min.css" integrity="sha384-1q8mTJOASx8j1Au+a5WDVnPi2lkFfwwEAa8hDDdjZlpLegxhjVME1fgjWPGmkzs7" crossorigin="anonymous">
  <link rel="stylesheet" href="https://code.jquery.com/ui/1.11.4/themes/smoothness/jquery-ui.css" />

<link rel="stylesheet" href="https://think-lab.s3.amazonaws.com/s/highlightjs/github.css" />
<link rel="stylesheet" href="https://think-lab.s3.amazonaws.com/s/css/css.css" />
<link rel="stylesheet" href="https://think-lab.s3.amazonaws.com/s/css/bootstrap-multiselect.css" />
<!-- <link href='https://fonts.googleapis.com/css?family=Open+Sans:400,700' rel='stylesheet' type='text/css'> -->

    
    
    
    
  
    <meta name="citation_doi" content="10.15363/thinklab.d65">
    <meta name="citation_title" content="Protein (target, carrier, transporter, and enzyme) interactions in DrugBank">
    <meta name="citation_online_date" content="May 9, 2015">
    <meta name="citation_author" content="Daniel Himmelstein, Sabrina Chen">
    <meta name="citation_journal_title" content="Thinklab">
    <meta name="citation_publisher" content="Thinklab">
  

    


	<!-- GoogleAnalytics -->
	<script>
	(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

	ga('create', 'UA-48550230-1', 'thinklab.org');
	ga('require', 'displayfeatures');
	
	ga('send', 'pageview');

	</script>






</head>
<body >
  <form id="form_action" method="post">
    <input type='hidden' name='csrfmiddlewaretoken' value='JC3hnVSWzcwBOS226QTq2eGyHXj1YAM6' />
</form>

	

	<div class="body-wrapper">

		


<!-- <div style="height:5px;background-image:url('https://think-lab.s3.amazonaws.com/s/img/top-bg.gif');"></div> -->
<div class="gradient">
	<div class="main-centered-div header-container">

<table class="full-width" style="height:60px;"><tr>
	<td style="width:200px;vertical-align:middle;padding-bottom:15px;">
		<a href="/" style="font-weight:normal;color:#212121;"><img src="https://think-lab.s3.amazonaws.com/s/img/logo.png" width="160"></a>
	</td><td style="vertical-align:middle;text-align:left;padding-top:6px;width:100%;padding-left:40px;">
		<ul id="not-search-block"  class="main-header">


			


				<li class="dropdown">
					<a class="dropdown-toggle" data-toggle="dropdown" href="#">Browse <span class="caret"></span></a>
					<ul class="dropdown-menu" role="menu">
						<li><a href="/proposals">Proposals</a></li>
						<li><a href="/projects">Projects</a></li>
						<li><a href="/publications">Article discussion</a></li>
						<li><a href="/discussion">All discussion</a></li>
					</ul>
				</li>
				<li><a href="/leaderboard">Leaderboard</a></li>

			
				<li><a href="/about">About</a></li>
			


		</ul>

    <ul id="search-block" class="main-header" style="display: none; margin-right: 30px;">
        <li class="full-width">
            <form method="get" action="/search">
			<div class="input-group full-width">
				<input name="q" type="text" class="form-control search-input">
			</div>
            </form>
        </li>
    </ul>

	</td><td style="vertical-align:middle;text-align:right;padding-top:6px; min-width: 1%; white-space: nowrap;">
		<ul class="main-header pull-right" style="padding-left: 0;">
    		
                <!-- <li><a href="/login" style="color:silver;">Login</a></li>
                <li style="margin-right:0"><a class="btn btn-default btn-sm btn-upper" href="/signup">Join</a></li> -->
            

        </ul>
    </ul>
	</td>
</tr></table>

<!-- <div id="global-search-div" class="main-centered-div" style="display:none;">
	<input type="text" value="" class="thread-search form-control" placeholder="Search" data-action="/discussion">
</div> -->

	</div>
</div>

		
	  



	  


		

		<div class="dark-head"><div class="main-centered-div">

			

		</div></div>
		
		<div class="main-centered-div" style="margin-top:40px;padding-bottom:340px">
	    

<div style="margin-top:-20px; margin-bottom:20px;">

    <a class="side-box" href="/p/rephetio" style="background-color:#ebfdff;"><div class="side-type">Project:</div> <div class="side-title">Rephetio: Repurposing drugs on a hetnet [rephetio]</div></a><br>



    <a class="side-box" href="/doi/10.1093/nar/gkt1068" style="background-color:#f0ffec;"><div class="side-type">Publication:</div> <div class="side-title">DrugBank 4.0: shedding new light on drug metabolism</div></a><br>

</div>

<table style="margin-top:0px;"><tr>
	<td class="thread-table-content">

		<table class="full-width">
			
<tr class="comment-tr target-hl" id="1" data-comment-id="212">
  <td class="comment-profile-avatar">
		<a href="/u/dhimmel"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/17_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="212"></a>

    

			<h2 class="page-title" style="margin-bottom:5px;margin-top:0px !important;">Protein (target, carrier, transporter, and enzyme) interactions in DrugBank</h2>

			<div style="margin-top:5px;color:gray;margin-bottom:20px;font-size:13px;">
				<a style="font-weight:normal;color:#212121" href="/u/dhimmel"><strong>Daniel Himmelstein</strong></a>
				<span class="is-researcher">Researcher</span>
				&nbsp; <a href="#1" class="light">May 9, 2015</a>
				
			</div>

      

          <hr>
		

    <p>DrugBank <a href="http://www.drugbank.ca/documentation">contains</a> four types of drug-protein interactions:</p>

<ul><li><strong>Target</strong>: A protein, macromolecule, nucleic acid, or small molecule to which a given drug binds, resulting in an alteration of the normal function of the bound molecule anda desirable therapeutic effect. Drug targets are most commonly proteins such as enzymes, ion channels, and receptors.</li><li><strong>Enzyme</strong>: A protein which catalyzes chemical reactions involving the a given drug (substrate). Most drugs are metabolized by the Cytochrome P450 enzymes.</li><li><strong>Transporter</strong>: A membrane bound protein which shuttles ions, small molecules or macromolecules across membranes, into cells or out of cells.</li><li><strong>Carrier</strong>: A secreted protein which binds to drugs, carrying them to cell transporters, where they are moved into the cell. Drug carriers may be used in drug design to increase the effectiveness of drug delivery to the target sites of pharmacological actions.</li></ul>

<p>We extracted DrugBank-protein interactions (<a href="http://nbviewer.ipython.org/github/dhimmel/drugbank/blob/22d835b3cd0ed421c18f855a85a183a9c1349e8f/parse.ipynb">notebook</a>, <a href="https://raw.githubusercontent.com/dhimmel/drugbank/22d835b3cd0ed421c18f855a85a183a9c1349e8f/data/proteins.tsv">download</a>). Our resource includes all DrugBank interactions that met the following criteria:</p>

<ol><li>The interaction is between a drug and <em>single</em> protein. A target which is "protein group" and contains multiple uniprot proteins would be excluded. Examples include the <a href="//www.drugbank.ca/biodb/bio_entities/BE0004797">GABA-A receptor (anion channel)</a> and <a href="//www.drugbank.ca/biodb/bio_entities/BE0004956">NMDA receptor</a>. Likewise, a target which is not a protein, such as <a href="//www.drugbank.ca/biodb/bio_entities/BE0004796">DNA</a> or <a href="//www.drugbank.ca/biodb/bio_entities/BE0004815">Phosphate</a>, would be excluded.</li><li>The protein maps to an entrez gene. Some uniprot proteins did not such as <a href="//www.uniprot.org/uniprot/Q7ZJM1">Q7ZJM1</a>, <a href="//www.uniprot.org/uniprot/Q59GM9">Q59GM9</a>, and <a href="//www.uniprot.org/uniprot/Q53ET4">Q53ET4</a> — all TrEMBL (unreviewed) terms with low <a href="http://www.uniprot.org/help/annotation_score">annotation scores</a>.</li></ol>

<p>In total, we extracted 19,906 interactions for 5,878 drugs and 3,757 genes.</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="2" data-comment-id="338">
  <td class="comment-profile-avatar">
		<a href="/u/sabrinachen"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/112_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="338"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/sabrinachen">Sabrina Chen</a>
				<span class="is-researcher">Researcher</span>
				<span class="light">&nbsp;<a href="#2" class="light">July 28, 2015</a>
          
        </span>
      </div>

    

    <h1>Similarities between associated genes in drug compounds</h1>

<p><a href="https://github.com/sabrinalchen/drugbank-similarity/blob/912848e1d13fc0648ae33e022308d1da719f5a1a/similarities.ipynb">Notebook</a></p>

<h2>Objective:</h2>

<p>We wanted to visualize the similarities among the associated genes for drug pairs in each of the four types of drug-bank interaction categories. To do so we extracted data from various sources to compile drugs with associated genes and the compound similarities between pairs of drugs compounds. </p>

<h2>The Data:</h2>

<p>We extracted <a href="https://raw.githubusercontent.com/dhimmel/drugbank/3e87872db5fca5ac427ce27464ab945c0ceb4ec6/data/proteins.tsv">DrugBank-protein relationships</a> which lists drug types and associated genes, as well as <a href="http://nbviewer.ipython.org/github/dhimmel/drugbank/blob/9eb1e15ada5e6579e5aea1cae784c10602037b05/similarity.ipynb">compound similarity data</a> which gives a value between zero and one based on the chemical similarity of a pair of drugs. </p>

<h2>Jaccard Values and Initial Visualization:</h2>

<p>Our first step was to create a dataframe with combination of compound pairs. Each compound is associated with a certain number of genes and we were able to define a Jaccard function to calculate the Jaccard value of the overlapping genes in each compound pair. It was noted – as expected — that the wide majority of the compound pairs had no similar genes, with a Jaccard value of zero. The drug-protein interactions were then categorized into four subgroups: carrier, enzyme, target and transporter. The similarity data was added for each compound pair. All five categories were graphed on a Seaborn PairGrid using a histogram on the univariate level and a hexbin scatterplot on the bivariate level.</p>

<h2>Analysis of PairGrid Jaccard Value Visualization:</h2>

<p>The data for each of the graphs did indeed center around zero, meaning that most compounds had no genes in common. In fact, the data was so skewed in the histogram that we needed to use logarithmic bins. Though the data was skewed right towards zero and dipped around 0.9 for each category, the histograms showed that there was also significant data for the Jaccard value of one, so that the graphs had U-shaped figures. This means that there are some compound pairs with all genes in common. In terms of the hexbin scatterplots, the darkest areas were zero and one, which reflected what was observed in the histograms. One other interesting trend to note are that for carrier and transporter, the data also concentrated around 0.5 and 0.33. </p>

<p><img src="https://raw.githubusercontent.com/sabrinalchen/drugbank-similarity/ad3edac94b5c8d00e81395095468c7cce621e9d6/figure/similarity.png" alt=""></p>

<h5>Figure 1: Compares Jaccard values for each drug-protein interaction category and chemical similarity</h5>

<h2>Mean Jaccard Pointplot:</h2>

<p>We used the Seaborn <a href="https://github.com/sabrinalchen/drugbank-similarity/blob/22bf54916d14b933be846bf52ad93237d54394c9/figure/similarity_mean.png">Pointplot</a> to visualize the data in a different way. The means of Jaccard values were calculated for each of the four protein-interaction categories. With the similarity on the x-axis and the mean of Jaccard on the y-axis, it was concluded that the mean Jaccard peaked when the similarity was about 0.8 to 0.9. The general upwards trend was expected, as increased compound similarity should indicate an increase of gene overlap. By far, the target category had the most dramatic increase in mean Jaccard value. Though it started with a pretty flat mean Jaccard value at zero, it increased rapidly to hit a mean Jaccard value of nearly 0.5 at similarity=0.8. </p>

<p><img src="https://raw.githubusercontent.com/sabrinalchen/drugbank-similarity/912848e1d13fc0648ae33e022308d1da719f5a1a/figure/similarity_mean.png" alt=""></p>

<h5>Figure 2: Demonstrates relationship between chemical similarity of compounds and the mean Jaccard values</h5>

<h2>Similarity Threshold:</h2>

<p>The final visualization we created was a series of complex barplots to compare a similarity threshold among the four category groups. The similarity values were replaced with zero or one depending on whether the original value was greater or less than 0.5. Next, contingency tables were created for each category so that relative frequencies could be calculated. </p>

<p>The visualization showed that similar compounds are likely to have common targets. For example, if two compounds shared a transporter, they also shared a carrier 25% of the time, compared to 5% of the time if they did not.  This trend continued throughout each of the bar graphs and was particularly notable in the comparisons with similarity. Note that the y-axis’s are labeled differently for easier reading. </p>

<p><img src="https://raw.githubusercontent.com/sabrinalchen/drugbank-similarity/ad3edac94b5c8d00e81395095468c7cce621e9d6/figure/output.png" alt=""></p>

<h5>Figure 3: Illustrates similarity threshold among the drug-protein interaction categories and chemical similarity</h5>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="3" data-comment-id="351">
  <td class="comment-profile-avatar">
		<a href="/u/dhimmel"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/17_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="351"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/dhimmel">Daniel Himmelstein</a>
				<span class="is-researcher">Researcher</span>
				<span class="light">&nbsp;<a href="#3" class="light">Aug. 4, 2015</a>
          
        </span>
      </div>

    

    <p>Great work <a href="/u/sabrinachen" class="username">@sabrinachen</a>! Your analysis reveals many interesting findings.</p>

<p>First, chemical similarity is a strong indicator that two compounds share a target (Figure 2). One of the most successful target prediction algorithms, named the Similarity Ensemble Approach (SEA) <span class="citation">[<a href="https://doi.org/10.1038/nature08506" class="citation" data-key="10.1038/nature08506">1</a>]</span>, is based on this very observation. Our data shows an enrichment of shared protein interactions above a chemical similarity threshold of 0.5. Interestingly, when binarizing chemical similarity scores, SEA also chose a cutoff of 0.5 (<a href="http://salilab.org/~nkhuri/files/systems-pharmacology-lecture4-01262015.pdf#page=19">source</a>).</p>

<p>Second, when two proteins share proteins of a specific category, they are more likely to share proteins of other categories (Figure 3). For example, when two compounds share a transporter, they have a 14% chance of sharing an enzyme, compared to 3% otherwise. This trend applies to all categories but is most pronounced between chemical similarity and target similarity.</p>

<p>Finally, it would be interesting to know how many compound pairs were included for each chemical similarity bin in Figure 2.</p>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

<tr class="comment-tr target-hl" id="4" data-comment-id="354">
  <td class="comment-profile-avatar">
		<a href="/u/dhimmel"><img class='profile_image photo-medium' src='https://think-lab.s3.amazonaws.com/m/profile/17_medium.jpg' width='60' height='60'></a>
  </td>
	<td class="comment-body">
    <a name="354"></a>

    

      <div class="comment-header">
        <a style="font-weight:bold;color:#212121" href="/u/dhimmel">Daniel Himmelstein</a>
				<span class="is-researcher">Researcher</span>
				<span class="light">&nbsp;<a href="#4" class="light">Aug. 5, 2015</a>
          
        </span>
      </div>

    

    <p>I contacted Mike Keiser, the human intellect behind SEA, regarding chemical similarity thresholding. Below and with permission, I've posted his reply to our <a href="#3">above</a> comment:</p>

<blockquote><p>The <a href="http://salilab.org/~nkhuri/files/systems-pharmacology-lecture4-01262015.pdf#page=19">0.5 measure</a> refers to a tanimoto coefficient on daylight path-based fingerprints. It'd be in the supplemental materials and/or methods of Keiser et al, Nat Biotechnol, 2007 <span class="citation">[<a href="https://doi.org/10.1038/nbt1284" class="citation" data-key="10.1038/nbt1284">1</a>]</span>. So I think the closest equivalent in rdkit would be tanimoto instead of dice coefficient, or rdkit-path fingerprints. Using ECFP4 (i.e., Morgan with radius 2 in rdkit) and a tanimoto coefficient, we found cutoffs more around 0.28 (the range can vary pretty substantially depending on fingerprint type used). In general, 0.5 is considered pretty high similarity for ECFP/Morgan fingerprints at least with tanimoto coefficients (I'm less sure of the Dice coefficient equivalents, off-hand).</p></blockquote>

		<div style="margin-left:30px;">

      


      <ul class="comment-notes">
				
				
			</ul>

      

		</div>

		


  </td>
</tr>

    		
		</table>

    

    &nbsp;<br>
    <!-- <a class="btn btn-primary btn-lg" href="/signup?next=/discussion/protein-target-carrier-transporter-and-enzyme-interactions-in-drugbank/65&suppress_message=1" style>Join to Reply</a> -->


		<table class="references table-td-5" style="display:none;"><tr><td><a href='/doi/10.1038/nature08506' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>1.</div></td><td><div class='doi-body' data-key='10.1038/nature08506'><a href='/doi/10.1038/nature08506' class='pub-title'>Predicting new molecular targets for known drugs</a><div class='pub-body'>Michael J. Keiser, Vincent Setola, John J. Irwin, Christian Laggner, Atheir I. Abbas, Sandra J. Hufeisen, Niels H. Jensen, Michael B. Kuijer, Roberto C. Matos, Thuy B. Tran, Ryan Whaley, Richard A. Glennon, Jérôme Hert, Kelan L. H. Thomas, Douglas D. Edwards, Brian K. Shoichet, Bryan L. Roth (2009) <i>Nature</i>. doi:<a class='pub-doi' href='https://doi.org/10.1038/nature08506'>10.1038/nature08506</a></div></div></td></tr><tr><td><a href='/doi/10.1038/nbt1284' class='pub-comments tt-right zero-items' title='Article comments'>0</a></td><td><div class='pub-order'>2.</div></td><td><div class='doi-body' data-key='10.1038/nbt1284'><a href='/doi/10.1038/nbt1284' class='pub-title'>Relating protein pharmacology by ligand chemistry</a><div class='pub-body'>Michael J Keiser, Bryan L Roth, Blaine N Armbruster, Paul Ernsberger, John J Irwin, Brian K Shoichet (2007) <i>Nat Biotechnol</i>. doi:<a class='pub-doi' href='https://doi.org/10.1038/nbt1284'>10.1038/nbt1284</a></div></div></td></tr></table>

    


	</td>
	<td class="thread-sidebar">


			

      <!-- <a class="btn btn-default follow-link btn-follow btn-lg is-following tt-top full-width" title="Follow discussion" data-id="65" data-ctype="thread" data-is-following="false">&nbsp;</a> -->

      
        <div class="status-box text-center"><span style="">Status:</span> 
  Completed

</div>
      

      
        
      


				

					<div class="details">Views</div>
					<span style="font-size:20px;">994</span>

        

				
					<div class="details">Topics</div>
					<div style="margin-bottom:15px;">
		            <a href="/topics/drugbank" class="tag">DrugBank</a><a href="/topics/databases" class="tag">Databases</a><a href="/topics/drug-targets" class="tag">Drug Targets</a>
					</div>
				


		
			<div class="details">Referenced by</div>
			<div style="font-size:12px;"><ul style="padding-left:16px !important;">
			
				<li>
					
					<a href='/d/186' class='thread-title'>Incorporating DrugCentral data in our network</a>
				</li>
			
				<li>
					
					Research report: <a href='/p/rephetio/report'>Rephetio: Repurposing drugs on a hetnet</a>
				</li>
			
				<li>
					
					<a href='/d/48' class='thread-title'>Text as a resource for network population?</a>
				</li>
			
				<li>
					
					<a href='/d/70' class='thread-title'>Calculating molecular similarities between DrugBank compounds</a>
				</li>
			
				</ul>
			</div>
		

		
			<div class="details">Cite this as</div>
			<span style="font-size:12px;">
				Daniel Himmelstein, Sabrina Chen (2015) Protein (target, carrier, transporter, and enzyme) interactions in DrugBank. <i>Thinklab.</i> doi:<a href='https://doi.org/10.15363/thinklab.d65'>10.15363/thinklab.d65</a>
			</span>
		

		<div class="details">License</div>
		<p><a rel="license" href="http://creativecommons.org/licenses/by/4.0/"><img alt="Creative Commons License" style="border-width:0;width:88px;height:31px;" src="https://i.creativecommons.org/l/by/4.0/88x31.png" /></a></p>

		<div class="details">Share</div>
		
			
				<a class="share-button fb" onclick="javascript:void(window.open('https://www.facebook.com/sharer/sharer.php?u=https%3A//thinklab.org/discussion/protein-target-carrier-transporter-and-enzyme-interactions-in-drugbank/65','','width=600,height=460,menubar=no,status=no'));" href="#"></a>
<a class="share-button twitter" onclick="javascript:void(window.open('https://twitter.com/share?text=Protein%20%28target%2C%20carrier%2C%20transporter%2C%20and%20enzyme%29%20interactions%20in%20DrugBank&url=https%3A//thinklab.org/discussion/protein-target-carrier-transporter-and-enzyme-interactions-in-drugbank/65','','width=600,height=300,menubar=no,status=no'));" href="#"></a>
<a class="share-button google" onclick="javascript:void(window.open('https://plus.google.com/share?url=https%3A//thinklab.org/discussion/protein-target-carrier-transporter-and-enzyme-interactions-in-drugbank/65','','width=510,height=460,menubar=no,status=no'));" href="#"></a>

			
		

	</td>
</tr></table>


		</div>


		
	    	<div class="footer">
<!-- <div style="background:#dedede;">
	<div class="main-centered-div text-center" style="padding:20px;">
		<h4 style="margin-bottom:0px;font-weight:bold;color:gray;">Feedback? Questions? Email us: <a href="mailto:hello@thinklab.com">hello@thinklab.com</a></h4>
	</div>
</div> -->
<div class="main-footer">
	<div class="main-centered-div">

<table class="full-width"><tr>
	<td class="footer-nav">

        <div class="foot-head">Explore</div>
        <a href="/proposals">Proposals</a><br>
        <a href="/projects">Projects</a><br>
        <a href="/publications">Article discussion</a><br>
        <a href="/discussion">All discussion</a><br>
        <a href="/topics">Topics</a><br>
        <!-- <a href="/funders">Funders</a><br> -->
        <a href="/funding">Funding opportunities</a><br>

	</td>
	<td class="footer-nav">

        <!-- <div class="foot-head">Help &amp; feedback</div>	 -->
        <!-- <div class="foot-head">Intro</div>
        <a href="/benefits/for-science">Why</a><br>
        <a href="/how-it-works">How it works</a><br>

<br> -->

        <div class="foot-head">Community</div>
        <a href="/leaderboard">Leaderboard</a><br>
        <a href="/p/meta">Thinklab Meta</a><br>
				<a href="/help/faq">Help</a><br>
				<!-- <a href="/new-project">Start a proposal</a><br> -->
        <!-- <a href="/benefits/proposal">Benefits</a><br> -->
        <!-- <a href="/funding">Get funded</a><br> -->
        <!-- <a href="/participate">Become a contributor</a><br> -->
        <!-- <a href="/for-funders">For science funders</a><br> -->
        <!-- <a href="/for-institutions">For institutions</a><br> -->

	</td>
	<td class="footer-nav">



        <div class="foot-head">About</div>
        <a href="/about">Overview</a><br>
        <a href="/benefits">Benefits</a><br>
        <a href="/how-it-works">How it works</a><br>
        <a href="/about/story">Our story</a><br>
        <a href="/blog">Our blog</a><br>
        <a href="/about/jobs">Join the team</a><br>
        <br>

        <!-- <div class="foot-head">Help</div>
        <a href="/help">Help</a><br>
		 -->


	</td>
	<td class="footer-nav">
		<!-- <a href="http://twitter.com/thinklab" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/twitter_com.png" width="40"/></a>
		<a href="https://www.facebook.com/pages/Thinklab/310895039088185" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/facebook_com.png" width="40"/></a>
		<a href="https://plus.google.com/115578983466800753402/" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/plus_google_com.png" width="40"/></a>
		<a href="https://www.linkedin.com/company/thinklab-co" class="social-icon"><img src="https://think-lab.s3.amazonaws.com/s/img/icons/linkedin_com.png" width="40"/></a> -->
		<br><br>
		<span class="light" style='font-size:12px;'>&copy; 2015 Thinklab</span>

	</td>

</tr></table>

</div>
</div>
</div>

		

	</div>


  <script></script>
  <script>
  var MEDIA_URL = 'https://think-lab.s3.amazonaws.com/m/';
  var STATIC_URL = 'https://think-lab.s3.amazonaws.com/s/';
  var page_is_authenticated = false;
  var page_page = 'discussion';
  var page_profile_id = undefined;
</script>



	<!-- Note different script type. MUST come before MathJax.js -->
	<script type="text/x-mathjax-config">
	    MathJax.Hub.Config({
	        "HTML-CSS": { preferredFont: "TeX", availableFonts: ["STIX","TeX"],
	                        scale: 110, linebreaks: { automatic:true },
	                        EqnChunk: (MathJax.Hub.Browser.isMobile ? 10 : 50) },
	        tex2jax: { inlineMath: [ ["$$", "$$"], ["\\(","\\)"] ],
	                    displayMath: [ ["$$$","$$$"], ["\\[", "\\]"] ],
	                    processEscapes: true,}
	            });

	</script>
    <script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>





  <script src="https://code.jquery.com/jquery-1.10.2.min.js"></script>
  <script src="https://code.jquery.com/ui/1.11.4/jquery-ui.min.js"></script>
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.6/js/bootstrap.min.js" integrity="sha384-0mSbJDEHialfmuBBQP6A4Qrprq5OVfW37PRR3j5ELqxss1yVqOtnepnHVP9aJ7xS" crossorigin="anonymous"></script>
  <script src="https://think-lab.s3.amazonaws.com/s/dist/main.min.js"></script>
  



  
	
  
  
  
<script>
$(function() {
  recordHit('thread', 65);
});
</script>



</body>
</html>
